|
|
 | | | |
- close
- close
- close
- close
Globe Newswire
Jul 6
Comment
IRVINE, Calif., July 6, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the acquisition of the company by C. R. Bard, Inc. (NYSE:BCR) was completed today. Under the terms of the merger agreement, SenoRx stockholders will
StreetInsider.com
Jul 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/SenoRx%2C+Inc.+%28SENO%29+trading+halted+for+info/5782692.html for the full story.
StreetInsider.com
May 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/SenoRx%2C+Inc.+%28SENO%29+Posts+Q1+Loss+of+%240.06%2C+Misses+Views/5601223.html for the full story.
Globe Newswire
May 5
Comment
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2010. Revenue for the quarter increased 4.3 percent to $13.4 million, compared with $12.9 million in the
Reuters
May 5
Comment
CR Bard agreed to buy
device-maker SenoRx for about $213 million in cash to
gain access to the company's devices used for the treatment of
breast cancer.
Globe Newswire
May 5
Comment
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced it has entered into a definitive merger agreement with C. R. Bard (NYSE:BCR) at a price of $11 per share, or approximately $213 million in the aggregate. The
Globe Newswire
Apr 8
Comment
IRVINE, Calif., April 8, 2010 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its First Quarter 2010 financial results on Thursday, May 6 at 8:00 a.m. PDT (11:00 a.m. EDT). The call
Globe Newswire
Mar 16
Comment
IRVINE, Calif., March 16, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) announced today that its Board of Directors appointed acting Chief Executive Officer John T. Buhler as the company's new Chief Executive Officer and a member of the Board
Globe Newswire
Mar 15
Comment
IRVINE, Calif., March 15, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today with great sadness announced the death of its Chairman and Chief Executive Officer, Lloyd H. Malchow. Mr. Malchow passed away Sunday evening, March 14. The company
Globe Newswire
Mar 15
Comment
LAS VEGAS, March 15, 2010 (GLOBE NEWSWIRE) -- It has been a very eventful year for SenoRx Inc. (Nasdaq:SENO) as the company focused on the intersection of women's health and oncology has seen its stock price rise precipitously and the grey clouds of
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
